Schroder Investment Management Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.07M | Sell |
|
|||||
|
2025
Q1 | $11.9M | Sell |
|
|||||
|
2024
Q4 | $14.4M | Buy |
|
|||||
|
2024
Q3 | $9.1M | Sell |
|
|||||
|
2024
Q2 | $18.9M | Sell |
|
|||||
|
2024
Q1 | $21.8M | Sell |
|
|||||
|
2023
Q4 | $26.1M | Buy |
|
|||||
|
2023
Q3 | $11.4M | Sell |
|
|||||
|
2023
Q2 | $12M | Sell |
|
|||||
|
2023
Q1 | $13.6M | Buy |
|
|||||
|
2022
Q4 | $14.4M | Buy |
|
|||||
|
2022
Q3 | $9.16M | Buy |
|
|||||
|
2022
Q2 | $1.01M | Buy |
|
|||||
|
2022
Q1 | $542K | Buy |
|
|||||
|
2021
Q4 | $435K | Buy |
|
|||||
|
2021
Q3 | $373K | Sell |
|
|||||
|
2021
Q2 | $427K | Buy |
|
|||||
|
2021
Q1 | $298K | Buy |
|
|||||
|
2020
Q4 | $338K | Sell |
|
|||||
|
2020
Q3 | $295K | Sell |
|
|||||
|
2020
Q2 | $528K | Sell |
|
|||||
|
2020
Q1 | $398K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $761K | Buy |
|